Jacques J. Genest
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Heart Failure Treatment and Management
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hormonal Regulation and Hypertension
Papers in
-
- Hormonal Regulation and Hypertension 132
- Diabetes, Cardiovascular Risks, and Lipoproteins 77
-
- Heart Failure Treatment and Management 72
- Renin-Angiotensin System Studies 52
- Co-authors
- M.-F. Cantin (87 shared papers)John J.P. Kastelein (13 shared papers)Paul M. Ridker (12 shared papers)Jolanta Gutkowska (114 shared papers)Jean G. MacFadyen (9 shared papers)Robert J. Glynn (9 shared papers)Børge Grønne Nordestgaard (9 shared papers)Peter Libby (8 shared papers)
- Journals
- Canadian Journal of Cardiology (34 papers)Atherosclerosis (31 papers)Canadian Journal of Physiology and Pharmacology (27 papers)Biochemical and Biophysical Research Communications (23 papers)Hypertension (20 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Jacques J. Genest
727 papers receiving 55.5k citations
Jacques J. Genest's Hit Papers
Peers
Comparison fields: 5 of 200
- Cardiology and Cardiovascular Medicine 14.7k
- Endocrinology, Diabetes and Metabolism 10.7k
- Surgery 19.7k
- Cancer Research 3.8k
- Immunology 5.1k
Countries citing papers authored by Jacques J. Genest
This map shows the geographic impact of Jacques J. Genest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques J. Genest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques J. Genest more than expected).
Fields of papers citing papers by Jacques J. Genest
This network shows the impact of papers produced by Jacques J. Genest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques J. Genest. The network helps show where Jacques J. Genest may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques J. Genest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 765 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Hit paper breakdown → | 2017 | 7350 |
| 2 | Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Hit paper breakdown → | 2008 | 5385 |
| 3 | Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Hit paper breakdown → | 2009 | 3240 |
| 4 | The Metabolic Syndrome and Cardiovascular Risk Hit paper breakdown → | 2010 | 2370 |
| 5 | Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency Hit paper breakdown → | 1999 | 1497 |
| 6 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 1106 |
| 7 | 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Hit paper breakdown → | 2016 | 974 |
| 8 | Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Hit paper breakdown → | 2009 | 849 |
| 9 | Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence Hit paper breakdown → | 1999 | 759 |
| 10 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial Hit paper breakdown → | 2017 | 743 |
| 11 | The Heart and the Atrial Natriuretic Factor* Hit paper breakdown → | 1985 | 703 |
| 12 | 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults Hit paper breakdown → | 2021 | 627 |
| 13 | 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations Hit paper breakdown → | 2009 | 623 |
| 14 | A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism Hit paper breakdown → | 2009 | 622 |
| 15 | 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Hit paper breakdown → | 2013 | 620 |
| 16 | Familial lipoprotein disorders in patients with premature coronary artery disease. Hit paper breakdown → | 1992 | 519 |
| 17 | Low density lipoprotein particle size and coronary artery disease. Hit paper breakdown → | 1992 | 468 |
| 18 | Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease Hit paper breakdown → | 2020 | 419 |
| 19 | NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS. Hit paper breakdown → | 1964 | 376 |
| 20 | 2018 | 368 |
About Jacques J. Genest
Jacques J. Genest is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Cancer Research and Molecular Biology, having authored 765 papers that have together received 59.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (156 papers), Hormonal Regulation and Hypertension (132 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (77 papers), Heart Failure Treatment and Management (72 papers), Cholesterol and Lipid Metabolism (56 papers), Receptor Mechanisms and Signaling (54 papers), Renin-Angiotensin System Studies (52 papers) and Cancer, Lipids, and Metabolism (47 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (14.7k citations), Endocrinology, Diabetes and Metabolism (10.7k citations), Surgery (19.7k citations), Cancer Research (3.8k citations) and Immunology (5.1k citations). Jacques J. Genest has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include M.-F. Cantin, John J.P. Kastelein, Paul M. Ridker, Jolanta Gutkowska, Jean G. MacFadyen, Robert J. Glynn, Børge Grønne Nordestgaard, Peter Libby, Antonio Gotto and Wolfgang Köenig. Their work appears in journals such as Canadian Journal of Cardiology, Atherosclerosis, Canadian Journal of Physiology and Pharmacology, Biochemical and Biophysical Research Communications and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.